Raphael Pharmaceutical Inc (RAPH)
1.00
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Raphael Pharmaceutical Cash from Financing (Quarterly): 0.019M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.019M |
| September 30, 2023 | 0.689M |
| June 30, 2023 | 0.288M |
| March 31, 2023 | 0.149M |
| December 31, 2022 | 0.472M |
| September 30, 2022 | 0.112M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.302M |
| March 31, 2022 | 0.01M |
| December 31, 2021 | 0.819M |
| September 30, 2021 | 0.10M |
| June 30, 2021 | 0.513M |
| March 31, 2021 | 0.044M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
0.01M
Minimum
Mar 2022
0.819M
Maximum
Dec 2021
0.2931M
Average
0.2185M
Median
Cash from Financing (Quarterly) Benchmarks
| InspireMD Inc | 0.00 |
| Pluri Inc | 0.00 |
| BiomX Inc | -1.324M |
| Alpha Tau Medical Ltd | -- |
| Holdco Nuvo Group DG Ltd | -- |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.088M |
| Free Cash Flow | -1.203M |
| Free Cash Flow Per Share (Quarterly) | -0.005 |
| Free Cash Flow Yield | -7.32% |